Repligen Corp (NASDAQ:RGEN)

40.04
Delayed Data
As of Jul 02
 -1.17 / -2.84%
Today’s Change
18.23
Today|||52-Week Range
42.48
+102.22%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close41.21
Today’s open41.24
Day’s range39.96 - 41.64
Volume218,334
Average volume (3 months)391,485
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio196.1
Price/Sales10.36
Price/Book11.74

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.12-0.99%
RPTPRaptor Pharmaceutica...+0.08+0.51%
ACORAcorda Therapeutics ...-0.01-0.03%
SRPTSarepta Therapeutics...+0.39+1.31%
Data as of 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers